Oral and intravenous pharmacokinetics of 5-fluoro-2′-deoxycytidine and THU in cynomolgus monkeys and humans

被引:0
|
作者
Julianne L. Holleran
Jan H. Beumer
David L. McCormick
William D. Johnson
Edward M. Newman
James H. Doroshow
Shivaani Kummar
Joseph M. Covey
Myrtle Davis
Julie L. Eiseman
机构
[1] University of Pittsburgh,Cancer Therapeutics Program, University of Pittsburgh Cancer Institute
[2] University of Pittsburgh,Department of Pharmaceutical Sciences, School of Pharmacy
[3] University of Pittsburgh,Department of Medicine, School of Medicine
[4] IIT Research Institute,Department of Cancer Biology
[5] City of Hope Beckman Research Institute,Division of Cancer Treatment and Diagnosis
[6] NCI,Department of Pharmacology and Chemical Biology, School of Medicine
[7] NIH,undefined
[8] University of Pittsburgh,undefined
[9] University of Pittsburgh Cancer Institute,undefined
[10] University of Pittsburgh Cancer Institute,undefined
来源
关键词
Fluorodeoxycytidine; Tetrahydrouridine; Toxicokinetics; Toxicity; Monkeys; DNA methylation inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:803 / 811
页数:8
相关论文
共 50 条
  • [31] UTILIZATION OF 5-FLUORO-2'-DEOXYURIDINE TRIPHOSPHATE AND 5-FLUORO-2'-DEOXYCYTIDINE TRIPHOSPHATE IN DNA-SYNTHESIS BY DNA POLYMERASE-ALPHA AND POLYMERASE-BETA FROM CALF THYMUS
    TANAKA, M
    YOSHIDA, S
    SANEYOSHI, M
    YAMAGUCHI, T
    [J]. CANCER RESEARCH, 1981, 41 (10) : 4132 - 4135
  • [32] GROWTH INHIBITION OF A HUMAN TUMOR CELL STRAIN BY 5-FLUOROCYTIDINE AND 5-FLUORO-2'-DEOXYCYTIDINE - REVERSAL STUDIES
    EIDINOFF, ML
    RICH, MA
    PEREZ, AG
    [J]. CANCER RESEARCH, 1959, 19 (06) : 638 - 642
  • [33] Comparison of the pharmacokinetics of subcutaneous and intravenous administration of a phosphorothioate oligodeoxynucleotide in cynomolgus monkeys
    Leeds, JM
    Henry, SP
    Geary, R
    Burckin, T
    Levin, AA
    [J]. ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2000, 10 (06): : 435 - 441
  • [34] ENZYMATIC CONVERSION OF 5-FLUORO-2'-DEOXYURIDINE TO 5-FLUOROURACIL OR 5-FLUORO-2'-DEOXYURIDINE 5'-MONOPHOSPHATE IN HUMAN TISSUES
    UCHIDA, M
    BROWN, N
    HO, DHW
    [J]. ANTICANCER RESEARCH, 1990, 10 (03) : 779 - 784
  • [35] A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine
    Newman, Edward M.
    Morgan, Robert J.
    Kummar, Shivaani
    Beumer, Jan H.
    Blanchard, M. Suzette
    Ruel, Christopher
    El-Khoueiry, Anthony B.
    Carroll, Mary I.
    Hou, Jessie M.
    Li, Chun
    Lenz, Heinz J.
    Eiseman, Julie L.
    Doroshow, James H.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 537 - 546
  • [36] MODE OF ACTION OF 5-FLUOROCYTIDINE AND 5-FLUORO-2'-DEOXYCYTIDINE IN L5178Y CELLS-INVITRO
    YOSHIDA, M
    HOSHI, A
    KURETANI, K
    SANEYOSHI, M
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1982, 30 (03) : 1018 - 1023
  • [37] PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2'-Deoxycytidine
    Gu, Di
    Dong, Kai
    Jiang, Aimin
    Jiang, Shaoqin
    Fu, Zhibin
    Bao, Yewei
    Huang, Fuzhao
    Yang, Chenghua
    Wang, Linhui
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine
    Edward M. Newman
    Robert J. Morgan
    Shivaani Kummar
    Jan H. Beumer
    M. Suzette Blanchard
    Christopher Ruel
    Anthony B. El-Khoueiry
    Mary I. Carroll
    Jessie M. Hou
    Chun Li
    Heinz J. Lenz
    Julie L. Eiseman
    James H. Doroshow
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 537 - 546
  • [39] CONVERSION OF ENCAPSULATED 5-FLUORO-2'-DEOXYURIDINE 5'-MONOPHOSPHATE TO THE ANTINEOPLASTIC DRUG 5-FLUORO-2'-DEOXYURIDINE IN HUMAN-ERYTHROCYTES
    DEFLORA, A
    ZOCCHI, E
    GUIDA, L
    POLVANI, C
    BENATTI, U
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) : 3145 - 3149
  • [40] CLINICAL STUDIES WITH 5-FLUORO-2'-DEOXYURIDINE
    ANSFIELD, FJ
    CURRERI, AR
    [J]. CANCER CHEMOTHERAPY REPORTS, 1960, (06): : 21 - 25